Shanghai Pharmaceuticals (Germany) Market Value
| S1R Stock | EUR 1.49 0.02 1.36% |
| Symbol | Shanghai |
Shanghai Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Shanghai Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Shanghai Pharmaceuticals.
| 09/27/2024 |
| 11/26/2024 |
If you would invest 0.00 in Shanghai Pharmaceuticals on September 27, 2024 and sell it all today you would earn a total of 0.00 from holding Shanghai Pharmaceuticals Holding or generate 0.0% return on investment in Shanghai Pharmaceuticals over 60 days. Shanghai Pharmaceuticals is related to or competes with Westinghouse Air, GEELY AUTOMOBILE, Fair Isaac, Commercial Vehicle, Norwegian Air, NORWEGIAN AIR, and Wizz Air. Shanghai Pharmaceuticals Holding Co., Ltd., an investment holding company, researches, develops, manufactures, distribut... More
Shanghai Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Shanghai Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Shanghai Pharmaceuticals Holding upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.47 | |||
| Information Ratio | 0.1081 | |||
| Maximum Drawdown | 21.18 | |||
| Value At Risk | (4.35) | |||
| Potential Upside | 6.92 |
Shanghai Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Shanghai Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Shanghai Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Shanghai Pharmaceuticals historical prices to predict the future Shanghai Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.1185 | |||
| Jensen Alpha | 0.5643 | |||
| Total Risk Alpha | (0.05) | |||
| Sortino Ratio | 0.1091 | |||
| Treynor Ratio | (0.87) |
Shanghai Pharmaceuticals Backtested Returns
Shanghai Pharmaceuticals appears to be dangerous, given 3 months investment horizon. Shanghai Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.15, which indicates the firm had a 0.15% return per unit of risk over the last 3 months. By inspecting Shanghai Pharmaceuticals' technical indicators, you can evaluate if the expected return of 0.54% is justified by implied risk. Please review Shanghai Pharmaceuticals' Risk Adjusted Performance of 0.1185, coefficient of variation of 690.45, and Semi Deviation of 2.68 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Shanghai Pharmaceuticals holds a performance score of 12. The entity has a beta of -0.57, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Shanghai Pharmaceuticals are expected to decrease at a much lower rate. During the bear market, Shanghai Pharmaceuticals is likely to outperform the market. Please check Shanghai Pharmaceuticals' downside deviation, total risk alpha, value at risk, as well as the relationship between the information ratio and treynor ratio , to make a quick decision on whether Shanghai Pharmaceuticals' existing price patterns will revert.
Auto-correlation | -0.37 |
Poor reverse predictability
Shanghai Pharmaceuticals Holding has poor reverse predictability. Overlapping area represents the amount of predictability between Shanghai Pharmaceuticals time series from 27th of September 2024 to 27th of October 2024 and 27th of October 2024 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Shanghai Pharmaceuticals price movement. The serial correlation of -0.37 indicates that just about 37.0% of current Shanghai Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.37 | |
| Spearman Rank Test | 0.2 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Shanghai Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Shanghai Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Shanghai Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Shanghai Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Shanghai Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Shanghai Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Shanghai Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Shanghai Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Shanghai Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Shanghai Pharmaceuticals Lagged Returns
When evaluating Shanghai Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Shanghai Pharmaceuticals stock have on its future price. Shanghai Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Shanghai Pharmaceuticals autocorrelation shows the relationship between Shanghai Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Shanghai Pharmaceuticals Holding.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Shanghai Stock
Shanghai Pharmaceuticals financial ratios help investors to determine whether Shanghai Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shanghai with respect to the benefits of owning Shanghai Pharmaceuticals security.